Get Shareable Link On June 26th to June 28th, 2019, the 2019 USA International medical device exhibition (FIME) was hold in Miami Beach convention center in Florida, USA. It was an honor for Wuhan Fine Biotech Co.; Ltd (brand name FineTest) to attend the FIME with its booth number I67. Explore new cooperation and …
As we know, Diabetes devastates nerve cells, which can lead to poor circulation, muscle weakness, blindness, and other painful side effects. According to a new study published in Experimental Neurology, cytokines might be the key to repairing diabetic nerve damage. In a mouse model of diabetes, researcher found out the diabetic mice owned the unusually low …
PD-1/PD-L1 interaction blocked by antibodies, freeing T cell to kill tumor cell www.fn-test.com 2018-10-22 KEYTRUDA (anti-PD-1(Programmed cell death protein 1) antibody) get approval of FDA. KEYTRUDA, Also called Pembrolizumab, is an anti-PD-1(Programmed cell death protein 1) antibody from humanized( from Mouse), which has been approved by the FDA. KEYTRUDA Could inhibit the PD-1/PD-L1 …
Get Shareable Link Mr. Tiong, the Director of Assaymatrix, had his first visit to Fine Test on 6th,June, 2018. Mr. Tiong was very impressed by the fast development of Fine Test. After visiting our R&D department, ELISA production department . We had in-depth discussion about Finetest products in Australian market and he was very satisfied …
No. Species CAT No. Description Sensitivity Range Detection method 1 Human EH0009 Human EGF(Epidermal Growth Factor) ELISA Kit 2.344pg/ml 3.906-250pg/ml Sandwich ELISA, Double Antibody 2 Human EH0011 Human IL-18(Interleukin 18) ELISA Kit 9.375pg/ml 15.625-1000pg/ml Sandwich ELISA, Double Antibody 3 Human EH0012 Human Lipocalin-2(Neutrophil Gelatinase Associated Lipocalin) ELISA Kit 0.188ng/ml 0.313-20ng/ml Sandwich ELISA, Double Antibody 4 …
Get Shareable Link Mr. Tim Bernard, the CEO of Pivotal Scientific Limited and the Director of 2BScientific Limited, had his first visit to Fine Test on Monday March 26th 2018. Tim was very impressed by the fast development of Fine Test after visiting our R&D department, ELISA production department and Sales department. We had in-depth …
Get Shareable Link Dan, the CEO of ARP American Research Products, Inc.™, had a visit to Fine Test on Monday March 26th 2018 and it was his second visit to Fine Test since March 2017. Dan visited our new offices at first and he was very impressed by our new laboratory facility as well as …
Get Shareable Link Mr. Luca Cicchett, the CEO of LaboSpace Srl from Italy, came to Fine Test for the second visit on March 23rd 2018, we were pleased to warm welcome his coming again. Accompanied by our CEO and technical manager, we showed him around our new lab since we had moved to the new …
Get Shareable Link Bio-connect Visit Fine Biotech’s New Facility in Hi-Tech Medical Devices Park Fine Biotech welcomed the delegation of Bio-connect from the Netherlands first week of May 2017. After touring around in Fine Biotech’s new established lab facilities (R&D centre) and marketing forces in B9 building in the Hi-tech medical devices park, No.818, Gaoxin …
A potential type 2 diabete drug Target— G protein–coupled receptor www.fn-test.com 2017-5-31 Human glucagon class B G-protein-coupled receptor (GCGR) is a 62 kDa protein which belongs to the class B G-protein-coupled receptor family. GCGR is a potential drug target for type 2 diabetes and plays a key role in glucose homeostasis and the pathophysiology of …
